Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 18, 2022

Monitoring of ctDNA Predicts Treatment Response and Early Progression in Follicular Lymphoma

Clinical Cancer Research

 

Additional Info

Clinical Cancer Research
Monitoring of circulating tumor DNA predicts response to treatment and early progression in follicular lymphoma: results of a prospective pilot study
Clin. Cancer Res 2022 Oct 21;[EPub Ahead of Print], I Fernández-Miranda, L Pedrosa, M Llanos, FF Franco, S Gómez, P Martín-Acosta, FR García-Arroyo, J Gumà, B Horcajo, AK Ballesteros, L Gálvez, N Martínez, M Marín, S Sequero, M Navarro, N Yanguas-Casás, V Calvo, A Rueda-Domínguez, M Provencio, M Sánchez-Beato

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading